Abstract:Rosmarinic acid (RA), one of the most important polyphenol-based antioxidants, has received growing interest because of its bioactive properties, including anti-inflammatory, anticancer, and antibacterial activities. Despite the high therapeutic potential of RA, its intrinsic properties of poor water solubility and low bioavailability have limited its translation into the clinic. Here, we report on the synthesis and preparation of PEGylated RA-derived nanoparticles (RANPs) and their use as a therapeutic nanomedicine for treatment of inflammatory bowel disease (IBD) in a dextran sulfate sodium (DSS)-induced acute colitis mouse model. PEGylated RA, synthesized via a one-step process from RA and a PEG-containing amine, self-assembled in buffer to form nanoparticles (RANPs) with a diameter of 63.5 ± 4.0 nm. The resulting RANPs showed high colloidal stability in physiological medium up to 2 weeks. RANPs were capable of efficiently scavenging H2O2, thereby protecting cells from H2O2-induced damage. Furthermore, the corticosteroid drug, dexamethasone (DEX), could be loaded into RANPs and released in response to a reactive oxygen species stimulus. Intravenously administered RANPs exhibited significantly improved pharmacokinetic parameters compared with those of the parent RA and were preferentially localized to the inflamed colon. Intravenous administration of RANPs in DSS-induced colitis mice substantially mitigated colonic inflammation in a dose-dependent manner compared with the parent RA, as evidenced by significantly reduced disease activity index scores, body weight loss, and colonic inflammatory damage. In addition, RANPs suppressed expression and production of typical pro-inflammatory cytokines in the inflamed colon. Furthermore, DEX-loaded RANPs showed enhanced therapeutic efficacy in the colitis model compared with bare RANPs at the equivalent dose, indicating synergy with a conventional medication. These findings suggest that RANPs deserve further consideration as a potential therapeutic nanomedicine for the treatment of various inflammatory diseases, including IBD.The Supporting Information is available free of charge at <a class="ext-link" href="/doi/10.1021/acsnano.0c01018?goto=supporting-info">https://pubs.acs.org/doi/10.1021/acsnano.0c01018</a>.1H NMR, MALDI-TOF, UV–vis absorbance, FT-IR data of RA, mPEG2k-NH2 and PEG-RA; schematic illustration of RANP formation; zeta potential, mobility, and conductivity values, particle size and stability data of RANPs; changes in the size of RANPs induced by ROS (H2O2) stimulation; schematic illustration of formation, HPLC analysis and particle size distribution data of ; therapeutic effects of RANPs at doses of 50 and 100 mg/kg; comparison of therapeutic effects between RA and RANPs; cross-sectioned H&E images of RANP-treated colons; muscle thickness of colon sections and estimated inflammation score in DSS-induced colitis mice; representative photomicrographs of IHC sections of colons for pSTAT3, NF-kB, and neutrophils; a table for assessment of DAI; a table for assessment of histopathological colitis (<a class="ext-link" href="/doi/suppl/10.1021/acsnano.0c01018/suppl_file/nn0c01018_si_001.pdf">PDF</a>)This article has not yet been cited by other publications.

Rosmarinic acid alleviates intestinal inflammatory damage and inhibits endoplasmic reticulum stress and smooth muscle contraction abnormalities in intestinal tissues by regulating gut microbiota

Rosmarinic acid alleviated intestinal barrier damage caused by Escherichia coli by regulating the gut microbiota and inhibiting the NF-κB signalling pathway in mice

Anti-inflammatory Effects of Rosmarinic Acid in Lipopolysaccharide-Induced Mastitis in Mice

Rosmarinic Acid Attenuates Salmonella enteritidis-Induced Inflammation via Regulating TLR9/NF-κB Signaling Pathway and Intestinal Microbiota

Moronic acid improves intestinal inflammation in mice with chronic colitis by inhibiting intestinal macrophage polarization

Protective Effect of Rosavin Against Intestinal Epithelial Injury in Colitis Mice and Intestinal Organoids

Anti-Inflammatory Effects of Rosmarinic Acid-Loaded Nanovesicles in Acute Colitis through Modulation of NLRP3 Inflammasome

Rosmarinic Acid, the Main Effective Constituent of Orthosiphon Stamineus, Inhibits Intestinal Epithelial Apoptosis Via Regulation of the Nrf2 Pathway in Mice

Rosmarinic Acid Attenuates the Lipopolysaccharide-Provoked Inflammatory Response of Vascular Smooth Muscle Cell via Inhibition of MAPK/NF-κB Cascade

Broad-Spectrum Reactive Oxygen Species Scavenging And Activated Macrophage-Targeting Microparticles Ameliorate Inflammatory Bowel Disease

Nanoparticles Derived from the Natural Antioxidant Rosmarinic Acid Ameliorate Acute Inflammatory Bowel Disease

Effects Of A Natural Prolyl Oligopeptidase Inhibitor, Rosmarinic Acid, On Lipopolysaccharide-Induced Acute Lung Injury In Mice

Rosmarinic acid represses colitis-associated colon cancer: A pivotal involvement of the TLR4-mediated NF-κB-STAT3 axis

Rosmarinic Acid Regulates Lipid Accumulation Through Lipid Metabolism and Anti-Inflammatory

Rosmarinic Acid Ameliorates Pulmonary Ischemia/Reperfusion Injury by Activating the PI3K/Akt Signaling Pathway

Rosmarinic Acid Protects Mice from Lipopolysaccharide/d-Galactosamine-induced Acute Liver Injury by Inhibiting MAPKs/NF-κB and Activating Nrf2/HO-1 Signaling Pathways.

Black rice anthocyanin-rich extract and rosmarinic acid, alone and in combination, protect against DSS-induced colitis in mice.

Rosmarinic acid exerts anti-inflammatory effect and relieves oxidative stress via Nrf2 activation in carbon tetrachloride-induced liver damage

Rosmarinic acid protects against experimental sepsis by inhibiting proinflammatory factor release and ameliorating hemodynamics.

Rosmarinic Acid Attenuates Airway Inflammation and Hyperresponsiveness in a Murine Model of Asthma.

Rosmarinic acid inhibits poly(I:C)-induced inflammatory reaction of epidermal keratinocytes